InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+177.4%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Geraghty James A, Directeur. Director active across 3 companies, notably Fulcrum Therapeutics, Inc.. Aggregated, 4 filings have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €77k. Activity tracked since 28 June 2021. The latest transaction was disclosed on 12 December 2024 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Geraghty James A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
1 股@ US$0.011.0% 占其流量Series F Preferred Stock, par value $0.001 per shareSEC:0001437749-24-037353:0
1 股@ US$1.0099.0% 占其流量Series F Preferred Stock, par value $0.001 per shareSEC:0001437749-24-032319:0
标准退出：2024年11月5日 (T+90)
44,391 股Ordinary SharesSEC:0000950170-24-007087:0
10,000 股@ US$9.16100.0% 占其流量Common StockSEC:0000899243-21-026552:0
标准退出：2021年9月26日 (T+90)
4 条申报中的 4 条
About Geraghty James A
James A. Geraghty is a Director at Fulcrum Therapeutics, Inc. He plays a key role in the governance of the company, bringing his experience to strengthen its strategy.
